Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06721338 · ClinicalTrials.gov registry record · Phase 1
Mechanical Thrombectomy Blood Flow Reversal
A Phase 1 study, sponsored by MediSys Health Network.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT06721338 is a Phase 1 study that was terminated before completion, run by MediSys Health Network. The registered enrollment target is 3 participants.
The verdict
NCT06721338, a Phase 1 study, was terminated before completion, sponsored by MediSys Health Network.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The goal of this study is to reduce the chance of complications during mechanical thrombectomy, which is a procedure to remove blockages from the brain. This study is combining two established and standard procedures for the first time so that the patient may benefit from both and reduce the chance of another stroke during the procedure. Our main goal is to show that this combination is safe, feasible, and effective for stroke patients. The combined procedures are described as follows: 1. Mechanical Thrombectomy: while the patient is asleep under light or general anesthesia, a surgical cut will be made in their groin to access the common femoral artery. A catheter will be inserted into this cut so that a wire can advance through the artery. Using an imaging technique called angiography, a blueprint is used to advance the wire from an artery in their groin, to their neck, into their brain and locate the target blockage. Once the target is located, more wires and catheters are used to finetune the extraction process. A stent retriever is placed on standby before removing the blockage. 2. Reversal Flow: before the mechanical thrombectomy is completed, a surgical cut will be made to the other groin that has not been operated on. A catheter and wire are used to access the newly punctured femoral vein. A device called an aspiration filter will connect a catheter from their femoral vein to an aspiration catheter at the target site. Once this connection is complete, full removal of the blockage by the stent retriever will occur while blood flow is reversed.
Interventions
- DEVICE Mechanical thrombectomy via blood flow reversal using BOBBY balloon guide catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2025-01-22 |
| Est. Completion | 2025-07-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06721338
The ClinicalTrials.gov registry entry for NCT06721338 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MediSys Health Network, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mechanical thrombectomy via blood flow reversal using BOBBY balloon guide catheter is the first listed.
NCT06721338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06721338 about?
NCT06721338 is a clinical study titled "Mechanical Thrombectomy Blood Flow Reversal". The goal of this study is to reduce the chance of complications during mechanical thrombectomy, which is a procedure to remove blockages from the brain. This study is combining two established and standard procedures for the first time so that the patient may benefit from both and reduce the chance ...
What is the current status of trial NCT06721338?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2025-01-22. Estimated completion is 2025-07-03.
What interventions are being tested in trial NCT06721338?
The interventions under investigation include: Mechanical thrombectomy via blood flow reversal using BOBBY balloon guide catheter (DEVICE).
Who is sponsoring clinical trial NCT06721338?
This trial is sponsored by MediSys Health Network, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.